$MDXH Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.22 down -46.67% YoY
• Mdxhealth maintains its 2026 revenue guidance of $110-115 million, representing 20-26% growth over 2025 excluding Resolve, and expects a return to positive adjusted EBITDA as Mdxhealth exits the year 2026.